A new stool-based test is showing promise in the noninvasive detection of colorectal cancer. The multitarget fecal immunochemical test showed higher detection rates across many different lesion and cancer types than traditional FIT in a study published in Lancet Oncology (2024;25[3]:326-337).
To support earlier and more accurate noninvasive CRC screening, researchers at the Netherlands Cancer Institute, the Erasmus MC and the Amsterdam UMC developed the mtFIT, which like a FIT evaluates